AI Assistant for Enhancing Colorectal Cancer Screening Among First-degree Relatives of Patients: a Randomized Trial

Launched by SUN YAT-SEN UNIVERSITY · Nov 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how an AI assistant can help improve the screening process for colorectal cancer among first-degree relatives (like parents, siblings, or children) of patients who have had this type of cancer. The goal is to see if using the ScreenTalk AI-based program, which includes three sessions of personalized messages and discussions, can encourage more people to get screened through colonoscopy. The researchers will check how many participants actually undergo screening by looking at their medical records and will also assess their beliefs about health at different times throughout the study.

To be eligible for this trial, participants should be between 40 and 75 years old, or at least 10 years younger than the age when their relative was diagnosed with colorectal cancer. They should have either one first-degree relative diagnosed with colorectal cancer before age 60 or two or more relatives diagnosed at any age. Participants must not have had a colonoscopy in the last five years and should be able to read and speak Chinese, as the program is delivered through WeChat. This trial is not yet recruiting participants, but it aims to find out if using technology can help save lives by increasing screening rates in those at higher risk.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 40 to 75 years or 10 years before the age at which the relative was diagnosed;
• • individuals with one FDR with CRC age \<60 years or with two or more FDRs with CRC at any age;
• • have not had a colonoscopy within 5 years;
• • access to WeChat themselves or through close family members living in the same household;
• • able to read and speak Chinese.
• Exclusion Criteria:
• • Have history of cancer or inflammatory bowel disease;
• • have history of a hereditary syndromes (Lynch syndrome or familial adenomatous polyposis);
• • recently participate in another study or previously participated in cancer risk counseling or study;
• • with doctor-diagnosed psychiatric illness.